Building a Substance Use Data Commons for Public Health Informatics

为公共卫生信息学建立药物使用数据共享区

基本信息

  • 批准号:
    10411763
  • 负责人:
  • 金额:
    $ 31.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-30 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Substance misuse comprises a complex set of conditions, often associated with comorbidities and social factors, that are the root cause of misuse and can lead to poor outcomes. Opioid misuse, non-opioid illicit use, and alcohol misuse can also lead to repeated encounters with hospital emergency departments or first-responders. Although substance use disorders are a leading cause of repeat hospital visits, our fragmented data systems do not generate comprehensive information on the scope and character of this poorly treated condition that would allow providers to improve and monitor the quality of care. Crucial social and behavioral determinants strongly linked with substance use (e.g., pre-hospital behavioral events) are not readily available to health systems, but they are important data that can be used to better train artificial intelligence/machine learning (AI/ML) models. In principle, hospitals are well-positioned to address these challenges. In practice, these opportunities are frequently missed given the fragmented structure and design of current data systems. Many patients living with substance misuse visit a specific hospital for the first time after an overdose or a related medical condition of drug use such as infection or trauma. Substance use-related conditions are among the top reasons for repeat visits to the hospital. This supplemental will expand on the existing work of the Parent R01, which is focused in clinical informatics, and build an AI/ML-ready public health informatics Substance Use Data Commons and share a novel, all-inclusive prediction model that will help guide clinical interventions and regional health policy. We aim to foster an academic-public-private collaboration to build a data ecosystem in this supplemental grant that will harmonize data across a Wisconsin regional hospital, pre-hospital agencies like fire, and public health agencies for the first time. We will build a cohort with substance misuse with linked data that are engineered as an AI/ML-ready data commons. During our one-year timeline, we will train and test an AI/ML model that can prioritize those at the highest risk for poor outcomes and uncover important biases in our data sources with input by health equity experts. The following goals are to be accomplished from the supplement proposal: (1) build a Substance Misuse Data Commons across a major hospital system and Wisconsin agencies; (2) develop and validate a machine learning tool for substance use-related health outcomes; and (3) examine model performance across health disparate groups (race/ethnic groups as well as neighborhoods). Access to combined data from hospitals, public health agencies, and first responder agencies could provide a comprehensive data resource that would allow us to reliably identify, risk stratify, and prioritize care for some of Wisconsin's most vulnerable residents through AI/ML modeling.
项目概要 药物滥用包括一系列复杂的情况,通常与合并症和社会因素有关, 这是滥用的根本原因,并可能导致不良结果。阿片类药物滥用、非阿片类药物非法使用,以及 滥用酒精还可能导致多次遇到医院急诊科或急救人员。 尽管物质使用障碍是重复去医院就诊的主要原因,但我们分散的数据系统确实 无法生成有关这种治疗不当的情况的范围和特征的全面信息 允许提供者改进和监控护理质量。重要的社会和行为决定因素 卫生系统不易获得与物质使用相关的信息(例如,院前行为事件),但 它们是重要的数据,可用于更好地训练人工智能/机器学习 (AI/ML) 模型。在 原则上,医院有能力应对这些挑战。在实践中,这些机会是 鉴于当前数据系统的分散结构和设计,经常会被遗漏。许多患者与 药物滥用 服药过量或出现相关医疗状况后首次前往特定医院就诊 使用药物,例如感染或外伤。与物质使用相关的情况是重复的主要原因之一 去医院就诊。本补充文件将扩展 Parent R01 的现有工作,重点是 临床信息学,并构建支持 AI/ML 的公共卫生信息学物质使用数据共享并共享 一种新颖的、包罗万象的预测模型,将有助于指导临床干预和区域卫生政策。 我们的目标是通过这笔补充赠款促进学术、公私合作,建立数据生态系统 这将协调威斯康星州地区医院、消防等院前机构和公共卫生部门的数据 机构首次。我们将通过链接数据建立一个药物滥用队列,这些数据被设计为 AI/ML 就绪的数据共享。在一年的时间内,我们将训练和测试一个 AI/ML 模型,该模型可以 优先考虑那些面临不良结果风险最高的人,并通过输入发现我们数据源中的重要偏差 由健康公平专家提出。补充提案要实现以下目标:(1)建立 主要医院系统和威斯康星州机构的药物滥用数据共享; (2) 开发和 验证与药物使用相关的健康结果的机器学习工具; (3) 检查模型性能 跨健康不同群体(种族/族裔群体以及社区)。访问组合数据 医院、公共卫生机构和急救机构可以提供全面的数据资源 这将使我们能够可靠地识别、风险分层并优先考虑对威斯康星州一些最弱势群体的护理 居民通过人工智能/机器学习建模。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Majid Afshar其他文献

Majid Afshar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Majid Afshar', 18)}}的其他基金

Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients
住院患者药物滥用识别的数据驱动策略
  • 批准号:
    10026785
  • 财政年份:
    2020
  • 资助金额:
    $ 31.06万
  • 项目类别:
CHANGE OF GRANTEE INSTITUTION 1 K23 AA024503 Alcohol, Burn-Injury, and Acute Respiratory Distress Syndrome
受资助者机构变更 1 K23 AA024503 酒精、烧伤和急性呼吸窘迫综合征
  • 批准号:
    10204442
  • 财政年份:
    2020
  • 资助金额:
    $ 31.06万
  • 项目类别:
Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients
住院患者药物滥用识别的数据驱动策略
  • 批准号:
    10265504
  • 财政年份:
    2020
  • 资助金额:
    $ 31.06万
  • 项目类别:
Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients
住院患者药物滥用识别的数据驱动策略
  • 批准号:
    10455043
  • 财政年份:
    2020
  • 资助金额:
    $ 31.06万
  • 项目类别:
Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients
住院患者药物滥用识别的数据驱动策略
  • 批准号:
    10671519
  • 财政年份:
    2020
  • 资助金额:
    $ 31.06万
  • 项目类别:
Alcohol, Burn-Injury, and Acute Respiratory Distress Syndrome
酒精、烧伤和急性呼吸窘迫综合征
  • 批准号:
    9543938
  • 财政年份:
    2016
  • 资助金额:
    $ 31.06万
  • 项目类别:
Alcohol, Burn-Injury, and Acute Respiratory Distress Syndrome
酒精、烧伤和急性呼吸窘迫综合征
  • 批准号:
    9338106
  • 财政年份:
    2016
  • 资助金额:
    $ 31.06万
  • 项目类别:
Alcohol, Burn-Injury, and Acute Respiratory Distress Syndrome
酒精、烧伤和急性呼吸窘迫综合征
  • 批准号:
    9765117
  • 财政年份:
    2016
  • 资助金额:
    $ 31.06万
  • 项目类别:
Proinflammatory Effects Of Acute Alcohol Ingestion in Humans
人类急性酒精摄入的促炎作用
  • 批准号:
    8594543
  • 财政年份:
    2013
  • 资助金额:
    $ 31.06万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.06万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了